Healthcare & Life Sciences

IMEL Biotherapeutics

Israel
Sign in to unlock

About

IMEL Biotherapeutics develops a cell-based therapy using proprietary Mitochondrial Replaced Cells technology aimed at treating patients with mitochondrial genetic and age-related disorders.

Explore IMEL Biotherapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing